Motley Fool Australia
  •  

    Notifications

    Scott

    Wondering where you should invest $1,000 right now?

    Scott Phillips just released his 5 best stocks to buy right now and you could grab the names of these stocks instantly!

    Learn More
  • Log Out
  • Menu
  1. Stocks
    2. /
  2. USCOM Ltd (ASX: UCM)
    3. /

USCOM Ltd (ASX: UCM) Share Price and News

Price

$0.02

Movement

0.00 (0.0)

As at 20 Jun - Closed (20 mins delayed)

52 Week Range

$0.011 - $0.045

 
1 Year Return

+25.0%

USCOM Ltd Chart and Price Data

2025
2025
2025
2025
$0.00
$0.02
$0.04
$0.00
$0.02
$0.04
$0.00
$0.02
$0.04
$0.00
$0.02
$0.04

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $5.01 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 250.48 million
Earnings per share -0.014
Dividend per share N/A
Year To Date Return -37.50%
Earnings Yield N/A
Franking -
Earnings Yield

N/A

Franking

-

Dividend per share

N/A

Year To Date Return

-37.50%

Shares Outstanding

250.48 million

Earnings per share

-0.014

Share Price

$0.02

Day Change

0.00 (0.0)

52 Week Range

$0.011 - $0.045

Yesterday's Close

$0.02

Today's Open

$0.017

Days Range

$0.017 - $0.02

Volume

457,706

Avg. Volume (1 month)

194,968

Turnover

$8,742

As at 20 Jun - Closed

    • USCOM Ltd (ASX: UCM)
    Latest News

    Two men react in shock at Evolution share price drop record profit
    Healthcare Shares

    The Uscom (ASX:UCM) share price plunged 6% today. Here's why

    | Lucas Radbourne

    The Uscom share price tumbled today after the company released its quarterly cash report, showing falls across every major category.

    Read more »

    a woman
    Share Gainers

    These ASX shares are fighting the spread of coronavirus

    | Kate O'Brien

    Some ASX shares are fighting coronavirus with demand for their products accelerating along with the spread of the virus. We…

    Read more »

    a woman
    Share Gainers

    Why this small-cap ASX healthcare share surged 39% higher today

    | Kate O'Brien

    The Uscom Ltd (ASX:UCM) share price surged 29% today after the Chinese government recommended one of its products for use…

    Read more »

    UCM ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    29th Apr 2025 2025-04-29T10:05:27 Quarterly Activities/Appendix 4C Cash Flow ReportYesNo10:05am7264k
    27th Feb 2025 2025-02-27T09:59:40 Half Yearly Report and AccountsYesNo9:59am17483k
    31st Jan 2025 2025-01-31T09:41:08 Quarterly Activities/Appendix 4C Cash Flow ReportYesNo9:41am7261k
    16th Jan 2025 2025-01-16T11:00:30 Related Party Short Term LoanYesNo11:00am157k
    31st Oct 2024 2024-10-31T09:45:45 Quarterly Activities/Appendix 4C Cash Flow ReportYesNo9:45am7257k
    29th Oct 2024 2024-10-29T09:23:01 Change of Director's Interest Notice - PhillipsYesNo9:23am3239k
    25th Oct 2024 2024-10-25T14:32:18 Notification regarding unquoted securities - UCMYesNo2:32pm616k
    25th Oct 2024 2024-10-25T14:22:08 Results of 2024 AGMYesNo2:22pm124k
    25th Oct 2024 2024-10-25T11:28:17 FY24 AGM Presentation and UpdateYesNo11:28am234.8M
    30th Sep 2024 2024-09-30T15:49:20 Notice of Annual General Meeting/Proxy FormYesNo3:49pm13437k

    About USCOM Ltd

    USCOM Ltd is engaged in the development, design, manufacture, and marketing of premium non-invasive cardiovascular and pulmonary medical devices. The company's geographical segment includes Australia, Asia, America, Europe, and Other regions. The company generates maximum revenue from Australia. The company offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, SPIROSONIC, a pulmonary function testing device based on multi-path ultrasound technology.

    UCM Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    20 Jun 2025 $0.02 $0.00 0.00% 457,706 $0.02 $0.02 $0.02
    10 Jun 2025 $0.02 $0.00 0.00% 540,396 $0.02 $0.02 $0.02
    05 Jun 2025 $0.02 $0.00 0.00% 446 $0.02 $0.02 $0.02
    04 Jun 2025 $0.02 $0.00 0.00% 65,447 $0.02 $0.02 $0.02
    03 Jun 2025 $0.02 $0.00 0.00% 1,376,000 $0.02 $0.02 $0.02
    02 Jun 2025 $0.02 $0.00 0.00% 608,640 $0.02 $0.02 $0.02
    30 May 2025 $0.02 $0.00 0.00% 1,000,000 $0.02 $0.02 $0.02
    29 May 2025 $0.02 $0.01 83.33% 133,012 $0.02 $0.02 $0.02

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    25 Oct 2024 Robert Phillips Issued 9,670,117 $250,027
    Director remuneration. 9,670,117 performance rights
    03 Jul 2024 Robert Phillips Issued 4,756,891 $85,624
    Conversion of securities.
    03 Jul 2024 Robert Phillips Exercise 4,756,891 $85,624
    Conversion of securities.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Brett Thomas Crowley Company SecretaryNon Executive director May 2016
    Mr Crowley is a practicing solicitor and a former Partner of Ernst & Young in Hong Kong and Australia, and of KPMG in Hong Kong and has worked in China establishing and managing JV companies there. Mr Crowley is an experienced chairman, finance director and company secretary of ASX-listed companies and is a former Senior Legal Member of the NSW Civil and Administrative Tribunal.
    Mr Robert Allan Phillips Chief Executive OfficerExecutive ChairmanExecutive Director Nov 2011
    Mr Phillips has 20 years of experience in corporate management since taking Uscom public in 2003 and has taken the company global with regional headquarters in Singapore, Beijing and Budapest with offices in Delawere.
    Mr Christian R Bernecker Non-Executive Director Nov 2011
    Mr Bernecker has more than 10 years of broad investment experience across capital raising, acquisitions and divestments.
    Mr Xianhui Meng Non-Executive Director Dec 2019
    Mr Meng has 10 years of experience as a China government departmental head, and 20 years of experience as the Executive Manager and Executive Director of a HK Listed Chinese Pharma specialising in sales and distribution. Mr Meng brings both his international corporate management and strategic skills to the Uscom Board.

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Mr Robert Allan Phillips 83,556,804 33.51%
    Citicorp Nominees Pty Limited 55,452,884 22.24%
    Neja Pty Ltd 17,633,368 7.07%
    HSBC Custody Nominees (Australia) Limited A/C 2 8,539,336 3.42%
    Jetan Pty Ltd <G R Plummer Super Fund A/C> 8,357,143 3.35%
    Invia Custodian Pty Limited <Bozwald Pty Ltd A/C> 4,228,931 1.70%
    Invia Custodian Pty Limited <Riverbel Family No 3 A/C> 3,490,141 1.40%
    Mr David Leroy Boyles 3,000,000 1.20%
    Ms Pamela Jack 2,845,212 1.14%
    Mr Douglas James Cameron 2,672,432 1.07%
    Mr Dongjun Sun 2,414,125 0.97%
    Mrs Christine Quye 2,268,150 0.91%
    Mr Rutherford James Browne & Mrs Sheba Elizabeth Marjorie Browne 2,121,991 0.85%
    Mr Perry Julian Rosenzweig 1,820,711 0.73%
    Mr Dean Leon Burrows & Mrs Kerry Ann Burrows 1,500,000 0.60%
    Mr Christopher James Were & Lockhart Trustee Services No 17 Limited <Christopher Were Family A/C> 1,424,095 0.57%
    Trentham Super Pty Ltd <Trentham Sf A/C> 1,351,000 0.54%
    Dr Choon Joo Kho 1,317,718 0.53%
    Mr Donald Allan Hammond 1,225,000 0.49%
    Mr Douglas James Cameron i 1,206,505 0.48%

    Profile

    since

    Note